Transgene

France
Illkirch-Graffenstaden, Grand Est, France, F-67405

Company profile

Transgene company profile

Transgene is an integrated biopharmaceutical company that designs and develops cutting-edge immunotherapeutic products to treat cancers and chronic infectious diseases. Their expertise covers all stages of product development, from research to the manufacture of clinical batches, and the conducting of clinical trials.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
501-1,000 employees
Revenue range
$0-$1M
Founded
1979-01-01, Year

Headquarters

Postal code
F-67405
Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
5
Total equity funding
$195.1M
Last funding
Post IPO Equity / $121.8M / 2025-11-26
Last equity funding
Post IPO Equity / $121.8M
Investors
1
Lead investors
1
Founders
1
Articles
114
Exited on
1998-03-26

Founders and investors

Founders

Pierre Chambon

Lead investors

Natixis

Investors

Natixis